184 related articles for article (PubMed ID: 21994769)
21. Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice.
Feuer G; Zack JA; Harrington WJ; Valderama R; Rosenblatt JD; Wachsman W; Baird SM; Chen IS
Blood; 1993 Aug; 82(3):722-31. PubMed ID: 8338942
[TBL] [Abstract][Full Text] [Related]
22. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H
Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181
[TBL] [Abstract][Full Text] [Related]
23. Cell death induced by dorsomorphin in adult T-cell leukemia/lymphoma is AMPK-independent.
Aikawa A; Kozako T; Uchida Y; Yoshimitsu M; Ishitsuka K; Ohsugi T; Honda SI
FEBS J; 2020 Sep; 287(18):4005-4015. PubMed ID: 32027454
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Eur J Pharmacol; 2020 Apr; 872():172953. PubMed ID: 31996318
[TBL] [Abstract][Full Text] [Related]
25. NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-kappaB signal pathway.
Okudaira T; Tomita M; Uchihara JN; Matsuda T; Ishikawa C; Kawakami H; Masuda M; Tanaka Y; Ohshiro K; Takasu N; Mori N
Mol Cancer Ther; 2006 Mar; 5(3):704-12. PubMed ID: 16546985
[TBL] [Abstract][Full Text] [Related]
26. Rigosertib is more potent than wortmannin and rapamycin against adult T-cell leukemia-lymphoma.
Ghorbanzadeh Neghab M; Jalili-Nik M; Soltani A; Afshari AR; Hassanian SM; Rafatpanah H; Rezaee SA; Sadeghnia HR; Ataei Azimi S; Mashkani B
Biofactors; 2023; 49(6):1174-1188. PubMed ID: 37345860
[TBL] [Abstract][Full Text] [Related]
27. Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol.
Ishikawa C; Tafuku S; Kadekaru T; Sawada S; Tomita M; Okudaira T; Nakazato T; Toda T; Uchihara JN; Taira N; Ohshiro K; Yasumoto T; Ohta T; Mori N
Int J Cancer; 2008 Dec; 123(11):2702-12. PubMed ID: 18798263
[TBL] [Abstract][Full Text] [Related]
28. Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.
Hiyoshi M; Okuma K; Tateyama S; Takizawa K; Saito M; Kuramitsu M; Araki K; Morishita K; Okada S; Yamamoto N; Biragyn A; Yamaguchi K; Hamaguchi I
Retrovirology; 2015 Aug; 12():73. PubMed ID: 26289727
[TBL] [Abstract][Full Text] [Related]
29. HTLV-1 and associated adult T-cell leukemia/lymphoma.
Mahieux R; Gessain A
Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
[TBL] [Abstract][Full Text] [Related]
30. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
[TBL] [Abstract][Full Text] [Related]
31. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
Arnulf B; Thorel M; Poirot Y; Tamouza R; Boulanger E; Jaccard A; Oksenhendler E; Hermine O; Pique C
Leukemia; 2004 Jan; 18(1):126-32. PubMed ID: 14574331
[TBL] [Abstract][Full Text] [Related]
32. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells.
Mori N; Yamada Y; Ikeda S; Yamasaki Y; Tsukasaki K; Tanaka Y; Tomonaga M; Yamamoto N; Fujii M
Blood; 2002 Sep; 100(5):1828-34. PubMed ID: 12176906
[TBL] [Abstract][Full Text] [Related]
33. [Clinical characteristics and prognosis in 12 patients with adult T cell leukemia/lymphoma confirmed by HTLV-1 provirus gene detection].
Wu ZJ; Zheng XY; Yang XZ; Liu TB; Yang T; Zheng ZH; Gao F; Chen CX; Li JG; Zhang CQ; Lin WQ; Zheng HY; Lin SX; Hu JD
Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1027-1032. PubMed ID: 28088963
[TBL] [Abstract][Full Text] [Related]
34. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells.
Darwiche N; El-Sabban M; Bazzi R; Nasr R; Al-Hashimi S; Hermine O; de Thé H; Bazarbachi A
Hematol J; 2001; 2(2):127-35. PubMed ID: 11424005
[TBL] [Abstract][Full Text] [Related]
36. Anti-tumor activity of 5-aminoimidazole-4-carboxamide riboside with AMPK-independent cell death in human adult T-cell leukemia/lymphoma.
Aikawa A; Kozako T; Kato N; Ohsugi T; Honda SI
Eur J Pharmacol; 2023 Dec; 961():176180. PubMed ID: 37956732
[TBL] [Abstract][Full Text] [Related]
37. Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.
Shigemura T; Shiohara M; Kato M; Furuta S; Kaneda K; Morishita K; Hasegawa H; Fujii M; Gorlach A; Koike K; Kamata T
J Virol; 2015 Sep; 89(17):9080-9. PubMed ID: 26109726
[TBL] [Abstract][Full Text] [Related]
38. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
Nakahata S; Morishita K
J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
[TBL] [Abstract][Full Text] [Related]
39. Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma.
El Hajj H; Khalil B; Ghandour B; Nasr R; Shahine S; Ghantous A; Abdel-Samad R; Sinjab A; Hasegawa H; Jabbour M; Hall WW; Zaatari G; Dbaibo G; Pisano C; Bazarbachi A; Darwiche N
Blood; 2014 Sep; 124(13):2072-80. PubMed ID: 25035162
[TBL] [Abstract][Full Text] [Related]
40. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]